Evidence map›Paper›PMID 29456532›Full record

ArticleFrontiers in immunology2018

A Stretch of Negatively Charged Amino Acids of Linker for Activation of T-Cell Adaptor Has a Dual Role in T-Cell Antigen Receptor Intracellular Signaling.

Mikel M Arbulo-Echevarria, Isaac Narbona-Sánchez, Cecilia M Fernandez-Ponce, Inmaculada Vico-Barranco, Mª Dolores Rueda-Ygueravide, Michael L Dustin, Arkadiusz Miazek, Mª Carmen Duran-Ruiz, Francisco García-Cózar, Enrique Aguado

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Increased Protein Stability and Interleukin-2 Production of a LATFrontiers in cell and developmental biology · 2020
    Article
  10. Article
  11. Beyond TCR Signaling: Emerging Functions of Lck in Cancer and Immunotherapy.International journal of molecular sciences · 2019
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Mikel M Arbulo-EchevarriaDepartment of Biomedicine, Biotechnology and Public Health (Immunology), Core Research Facility for Health Sciences, University of Cádiz and Puerto Real University Hospital Research Unit, Cádiz, Spain.
Isaac Narbona-SánchezDepartment of Biomedicine, Biotechnology and Public Health (Immunology), Core Research Facility for Health Sciences, University of Cádiz and Puerto Real University Hospital Research Unit, Cádiz, Spain.
Cecilia M Fernandez-PonceDepartment of Biomedicine, Biotechnology and Public Health (Immunology), Core Research Facility for Health Sciences, University of Cádiz and Puerto Real University Hospital Research Unit, Cádiz, Spain.
Inmaculada Vico-BarrancoDepartment of Biomedicine, Biotechnology and Public Health (Immunology), Core Research Facility for Health Sciences, University of Cádiz and Puerto Real University Hospital Research Unit, Cádiz, Spain.
Mª Dolores Rueda-YgueravideServicio de Neumología-Alergia, Hospital Puerta del Mar, Cádiz, Spain.
Michael L DustinNuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, The Kennedy Institute of Rheumatology, The University of Oxford, Headington, United Kingdom.
Arkadiusz MiazekHirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland.
Mª Carmen Duran-RuizDepartment of Biomedicine, Biotechnology and Public Health (Biochemistry), University of Cádiz, Cádiz, Spain.
Francisco García-CózarDepartment of Biomedicine, Biotechnology and Public Health (Immunology), Core Research Facility for Health Sciences, University of Cádiz and Puerto Real University Hospital Research Unit, Cádiz, Spain.
Enrique AguadoDepartment of Biomedicine, Biotechnology and Public Health (Immunology), Core Research Facility for Health Sciences, University of Cádiz and Puerto Real University Hospital Research Unit, Cádiz, Spain.
Universidad de Cádiz · ESBiomedical Research and Innovation Institute of Cadiz · ESHospital Universitario Puerta del Mar · ESLudwik Hirszfeld Institute of Immunology and Experimental Therapy · PLUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The adaptor protein linker for activation of T cells (LAT) has an essential role transducing activatory intracellular signals coming from the TCR/CD3 complex. Previous reports have shown that upon T-cell activation, LAT interacts with the tyrosine kinase Lck, leading to the inhibition of its kinase activity. LAT-Lck interaction seemed to depend on a stretch of negatively charged amino acids in LAT. Here, we have substituted this segment of LAT between amino acids 113 and 126 with a non-charged segment and expressed the mutant LAT (LAT-NIL) in J.CaM2 cells in order to analyze TCR signaling. Substitution of this segment in LAT prevented the activation-induced interaction with Lck. Moreover, cells expressing this mutant form of LAT showed a statistically significant increase of proximal intracellular signals such as phosphorylation of LAT in tyrosine residues 171 and 191, and also enhanced ZAP70 phosphorylation approaching borderline statistical significance (

Indexed as

Adaptor Proteins, Signal TransducingAmino AcidsCell LineHumansLymphocyte Specific Protein Tyrosine Kinase p56(lck)Membrane ProteinsReceptors, Antigen, T-CellZAP-70 Protein-Tyrosine KinaseAdaptor Proteins, Signal TransducingAmino AcidsLAT protein, humanLymphocyte Specific Protein Tyrosine Kinase p56(lck)Membrane ProteinsReceptors, Antigen, T-CellZAP70 protein, humanZAP-70 Protein-Tyrosine KinaseCD3LATLcksignalingTCR

Identifiers

PMID29456532
PMCPMC5801411
OpenAlexW2791409281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.